The global blood market is expected to grow by CAGR of 9.27% during the forecasted period 2016-2022. The major factor contributing towards the growth in market isincreasing aging population and accumulative prevalence of peripheral vascular diseases. The increasing aging population is having a huge impact on the growth of global blood market. According to WHO, the world aged population has been expected to reach 2 billion by the end of 2050 which was 900 million in 2015. Now there are around 125 million people aged 80 years or more. By the end of 2050 almost 125 million people aged 80 years or more has been expected to reach in China alone and 434 million people across the globe. So increasing aging population is one of the major driving factor of global blood market.

The global cardiac equipment technologies market is expected to grow at the CAGR of 5.9 % during 2016-2022 and is expected to reach $71000 million till 2022. Cardiac devices are the devices which are being used by hospitals, other cardiac centers when a patient is suffering from cardiac arrest. Defibrillators, pacemaker, ECG machines are some of the examples of cardiac devices.

The global drug and alcohol testing market is expected to grow by CAGR of 10.1% during the forecasted period 2016-2022. The major factors contributing towards the growth of market isintensifying world population and increasing use of drugs and alcohol across the globe. The market is also driven by various factors such as portrayal of stringent laws mandating drug and alcohol testing and rising government funding. The increasing drug and alcohol abuse is one of the major factor driving the growth in the global market.

The global pain management drugs and devices marketwas estimated to grow around $37.8 billion in 2015 and it is forecasted to reach around $50.76 billion at a CAGR of 4.3% during 2015-2022. The major factor driving theglobal pain management drugs and devices market is rising number of chronic pain disorders in all over the world like cancer, migraine etc. along with rising geriatric population which will be boosting the growth of the pain management drugs and devices market in next decade.Usageof pain management devices is rising in all over the world due to growing technological advancements in medicalfield as well as rising medical tourism is expected to drive this market.

The global spirometer market has generated revenue of approx. $533 million in 2015 and is anticipated to generate approx. $1039 million in 2022 growing at a CAGR of approx. 10%. The drivers which grow the market are the rising aging population, growing incidences of chronic diseases, and advancement of technology in the field of respiratory care devices. Due to increase in the number of cases such as asthma and multiple sclerosis and chronic diseases like cancer and diabetes, there has been an increase in the demand of diagnostic devices globally which in turn has accelerated the market of spirometers worldwide.

The global in vitro diagnostics market is expected to grow at the CAGR of 6.4% during 2015-2022. The major factors driving the market are the rising rate of gastrointestinal diseases and the growth in geriatric population. According to census.gov, approx. 47.5 million people were aged 65 and above in the U.S. and are anticipated to reach around 60 million by the end of 2022.

The global renal disease treatments technology market is expected to grow at the CAGR of 6.8% during 2015-2022, and is expected to reach the $86 billion mark by 2022. The global renal disease treatment market is expected to grow at a rapid pace due to rising incidences of chronic kidney diseases and end stage renal diseases. Rising lifestyle associated diseases and rising patient’s base of hypertension are the two major reasons behind kidney related diseases that are expected to drive the demand of global renal diseases treatment technology market during the forecast year.

The Allergy Diagnostics and Therapeuticsmarketis expected to grow with CAGR of 12.67% in period of 2015-2022. The major factors that are driving the global Allergy Diagnostics and therapeutics market are increasing allergic diseases, growing IVD markets, increasing healthcare expenditure and increasing laboratory automation. Increasing respiratory allergic cases day by day increased the market of allergy diagnostics and therapeutics.

The blood testing technologymarket is expected to grow at the CAGR of 10.5% during 2015-2022. The major factors driving the market are increasing patient population, growing healthcare centers and technological advancements. The patient population is increasing gradually due to growing infectious diseases such as viral, cancer, HIV, genetic disorder, thyroid which enhance the need for blood testing resulting in expansion of blood testing technology market. Growing healthcare center is another factor affecting the market.

Information technology is used to design, develop and maintain the information in healthcare industry. Information technology offers solutions for data management and security of healthcare information. Factors such as growing medical tourism, rise in aging population, rising prevalence of chronic diseases and growing demand for advance medications are driving the market of Healthcare IT.

The global mobile health technology market is expected to grow at the CAGR of 33.3% during 2015-2022. The mobile health technology market is driven by a number of factors such as high penetration of smartphones in developed countries and rising number of users in the developing countries. Also there can be seen an inclination towards personal care from hospital care, Mhealth provides seamless support and personal care to the patients and this is again a big reason for the rising use of the technology.

The global diagnostics and therapeutics for lung cancer market is expected to grow at the CAGR of 8% during 2015-2022. The global diagnostics and therapeutics for lung cancer market would be driven by increasing adoption of personalized treatments. Lung cancer also called pulmonary carcinoma is a type of cancer characterized by uncontrolled cell growth in the lungs.

The most important factor in the growth of global technologies for long term care and home healthcare market is the advancements in technologies in healthcare market. Rising geriatric population and increasing need for economical treatment options has led to the growth of the technology for long term care. In addition to adoption of technology and broadband connectivity by elderly people has made a significant impact in the demand for the services of home care.

Global Healthcare Analytics Market is expected to grow at the CAGR of XX% during 2015-2022 and it estimated to be $XX billion by 2022. The Global Healthcare Analytics Market is majorly driven by the technological advancement in healthcare domain. Reduction in healthcare cost and government support for research and development is driving the market. Global adoption of healthcare analytics has created huge scope in the market.

The global Body Fat Measurement market is expected to grow at a CAGR of 9% during the forecast period of 2015-2022, to reach $700.3 million in 2022. The body fat measurement have different methods for body composition analysis globally. These methods are different from each other in terms of pricing, availability, complexity of testing process and parameters for accuracy.

The Global medical gases market is expected to grow at the CAGR of 8.5% during 2015-2022 and it estimated to be $14 billion by 2022. The Global medical gases market is majorly driven by aging population and the resultant increase in the prevalence of chronic respiratory diseases as well as advancements in the pharmaceutical industry.

The global medical robotics market is expected to grow at a CAGR of 12% during 2015-2022 and is estimated to be approximately $XX billion at the end of the forecasted period i.e. by 2022. The global market for medical robotics is driven by strong need for errorless healthcare services.

The global catheters market is growing productively, was valued at US$ 14.6 Bn in 2017 and expected to reach US$ 28.4 Bn by 2026. Globally increasing surgical procedures, the high prevalence of cardiovascular diseases (majorly congestive heart failure, cardiac arrhythmia, and cardiac arrest), kidney diseases and urinary tract infections has significantly boosted the market growth in the current years.

The global anti-aging products and services market is exceptionally fuelled with the aid of the increasing population base all around the globe. The anti-aging market continues to be considered to be a constructing market because the patrons are nonetheless skeptical about some of the products and services being supplied within this market. This element could hinder the progress of the market within the forecasted years.